Ulcerative colitis

April 14, 2016April 14, 2016

Sherman Prize for Excellence in Crohn’s and Colitis Accepting Online Nominations

Crohn's Disease, IBD News, News, Ulcerative colitis

The Bruce and Cynthia Sherman Charitable Foundation announced it is seeking online nominations for the Sherman Prize for Excellence in Crohn’s and Colitis, also known as the Sherman Prize, to ... Read more

April 6, 2016April 6, 2016

CHMP Issues Positive Opinion on Samsung Bioepis’ Flixabi, a Biosimilar Treatment for IBD

Crohn's Disease, IBD News, News, Ulcerative colitis

The Committee for Medicinal Products for Human Use (CHMP), the scientific board of European Medicines Agency, has issued a positive opinion on Samsung Bioepis’ Flixabi for the treatment of ulcerative colitis (UC) ... Read more

April 4, 2016May 17, 2016

Crohn’s & Colitis Foundation Elects 5 New Trustees to Join National Board

Crohn's Disease, IBD News, News, Ulcerative colitis

The Crohn’s & Colitis Foundation of America (CCFA) recently announced Donald Kortz, Mark Murray, Marcy Nanus, Joseph Nemmers and Robert “Van” Pulley as the most recent members of the foundation’s ... Read more

March 29, 2016March 29, 2016

Pfizer Oral Drug, Tofacitinib, for Ulcerative Colitis Meets Key Endpoints in Phase 3 Studies

IBD News, News, Ulcerative colitis

Pfizer, Inc., recently announced that its investigational oral drug tofacitinib has met primary and key secondary endpoints in two Phase 3 studies evaluating its efficacy and safety in inducing remission in ... Read more

March 24, 2016May 17, 2016

UC Patients Taking Ozanimod in Phase 2 Trial Show Histologic Improvement, Celegene Reports

News, Ulcerative colitis

Celgene International Sàrl, a subsidiary of Celgene Corporation, has announced the release of additional data on exploratory endpoints from its Phase 2 clinical trial assessing ozanimod in people with moderate to severe ulcerative colitis (UC). The data, ... Read more

March 23, 2016March 23, 2016

Ulcerative Colitis Patients Appear More Worried About IBD Complications Than Treatment Side Effects

Colon Cancer, IBD News, News, Ulcerative colitis

People with ulcerative colitis (UC) are more concerned about the long-term complications of their inflammatory bowel disease (IBD) than they are about possible side effects from its treatment, according to an online survey of UC patients ... Read more

March 22, 2016March 24, 2016

Device for Detecting IBD via Calprotectin Levels in Stool Being Evaluated in UK Study

Crohn's Disease, IBD News, News, Ulcerative colitis

Origin Sciences Ltd has initiated a performance study of its OriCol device in measuring calprotectin, a validated biomarker of inflammation, in the stool and rectal mucus of people with known or suspected cases of inflammatory bowel disease (IBD). IBD ... Read more

March 16, 2016September 28, 2016

Ulcerative Colitis IND Trial Application Cleared by FDA for InDex’s Cobitolimod

IBD News, News, Ulcerative colitis

The U.S. FDA has cleared InDex Pharmaceuticals AB’s Investigational New Drug (IND) application to launch a Phase 2b clinical trial for cobitolimod (Kappaproct) in patients with moderate to severe ulcerative colitis (UC). ... Read more

March 8, 2016May 17, 2016

Crohn’s Patients Report Making 10 or More Doctor Visits Before Receiving a Diagnosis

Crohn's Disease, IBD News, News, Ulcerative colitis

A nationwide survey of Crohn’s disease patients found a considerable delay in diagnosing the disease, with patients reporting multiple visits with healthcare professionals and numerous diagnostic tests before receiving a proper determination. In fact, 44 ... Read more

March 3, 2016March 4, 2016

For Crohn’s Disease and Ulcerative Colitis, Company Reveals Results of New Study and Is Recruiting for Clinical Trial

Crohn's Disease, IBD News, News, Ulcerative colitis

Immune Pharmaceuticals recently published new data on the impact of eotaxin-1 in ulcerative colitis (UC) and Crohn’s disease (CD). The article, “The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New ... Read more